scispace - formally typeset
G

Gisbert Schneider

Researcher at ETH Zurich

Publications -  483
Citations -  24401

Gisbert Schneider is an academic researcher from ETH Zurich. The author has contributed to research in topics: Virtual screening & Pharmacophore. The author has an hindex of 68, co-authored 482 publications receiving 20364 citations. Previous affiliations of Gisbert Schneider include Max Planck Society & Charité.

Papers
More filters
Journal ArticleDOI

Designing antimicrobial peptides: form follows function

TL;DR: In this article, advanced computer assisted design strategies that address the difficult problem of relating primary sequence to peptide structure, and are delivering more potent, cost-effective, broad-spectrum peptides as potential next-generation antibiotics.
Journal ArticleDOI

Computer-based de novo design of drug-like molecules

TL;DR: This review outlines the various design concepts and highlights current developments in computer-based de novo design of hit and lead structure candidates for drug discovery projects.
Journal ArticleDOI

Counting on natural products for drug design

TL;DR: This work highlights the potential of innovative computational tools in processing structurally complex natural products to predict their macromolecular targets and attempts to forecast the role that natural-product-derived fragments and fragment-like natural products will play in next-generation drug discovery.
Journal ArticleDOI

“Scaffold-Hopping” by Topological Pharmacophore Search: A Contribution to Virtual Screening

TL;DR: A chemically advanced template search based on topological pharmacophore models has been developed as a technique for virtual screening and has successfully identified novel potent Ca(2+) antagonists in a library of several hundred thousand compounds on the basis of a correlation vector representation.
Journal ArticleDOI

Deep Learning in Drug Discovery.

TL;DR: An overview of this emerging field of molecular informatics, the basic concepts of prominent deep learning methods are presented, and motivation to explore these techniques for their usefulness in computer‐assisted drug discovery and design is offered.